GlobeNewswire 12/11/2025 ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Followin...
GlobeNewswire 10/11/2025 Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Busi...
GlobeNewswire 10/11/2025 Nokia appoints Kristen Pressner as Chief People Officer and member of the Group Leadership Team
GlobeNewswire 10/11/2025 [Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib shows unprecedented positive Phase...
GlobeNewswire 07/11/2025 Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC an...
GlobeNewswire 07/11/2025 Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immu...
GlobeNewswire 07/11/2025 ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire 06/11/2025 Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire 06/11/2025 TREOS Bio Announces Publication of Phase 1b Clinical Trial Results of PolyPEPI1018 Plus TAS-102 in R...
GlobeNewswire 06/11/2025 Monte Rosa Therapeutics Announces Third Quarter 2025 Financial Results and Business Updates
GlobeNewswire 05/11/2025 Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
GlobeNewswire 05/11/2025 Royalty Pharma Reports Third Quarter 2025 Results
GlobeNewswire 05/11/2025 Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 04/11/2025 Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherape...
GlobeNewswire 04/11/2025 Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire 04/11/2025 Indicium and Mesh-AI Join Forces to Create a Global Data and AI Powerhouse
GlobeNewswire 03/11/2025 Roche to present new data from its broad and innovative haematology portfolio at ASH 2025
GlobeNewswire 03/11/2025 Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer
GlobeNewswire 03/11/2025 BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
GlobeNewswire 03/11/2025 Positive phase III data for Roche’s Gazyva/Gazyvaro show significant reduction in disease activity f...
GlobeNewswire 30/10/2025 Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients wi...
GlobeNewswire 30/10/2025 Roche purchases shares in tender offer for 89bio, Inc
GlobeNewswire 29/10/2025 Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue
GlobeNewswire 28/10/2025 Step Therapy Shifts and Pipeline Momentum Reshape the Membranous Nephropathy Treatment Landscape, ac...
GlobeNewswire 28/10/2025 BioNTech to Host Innovation Series R&D Day on November 11, 2025